Stovall T G
Section on Gynecology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC 27157-1066, USA.
Clin Obstet Gynecol. 1995 Jun;38(2):346-52. doi: 10.1097/00003081-199506000-00018.
It does not appear that methotrexate can or should be used to totally replace laparoscopic salpingostomy. However, given its success rate in selected patients, its cost-effectiveness, and its low incidence of side effects, methotrexate therapy certainly can be used as an alternative therapy. The next step in developing this treatment option will be to conduct a randomized clinical trial comparing laparoscopic salpingostomy with intramuscular methotrexate. This type of study will answer questions regarding the patient's health related quality of life and economic impact of the two treatment modalities. For now, it seems prudent to offer methotrexate to those patients with an unruptured ectopic gestational mass 3.5 cm or less in greatest dimension.
